SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $57 | -72.9% | 12,250 | -73.1% | 0.00% | -80.0% |
| Q1 2023 | $210 | -99.9% | 45,540 | +105.2% | 0.01% | -16.7% |
| Q1 2022 | $182,000 | -59.6% | 22,189 | -26.7% | 0.01% | -78.6% |
| Q4 2021 | $450,000 | -30.2% | 30,262 | -11.4% | 0.06% | -34.9% |
| Q3 2021 | $645,000 | +53.9% | 34,152 | +51.5% | 0.09% | -39.0% |
| Q2 2021 | $419,000 | -59.8% | 22,550 | -50.8% | 0.14% | -57.7% |
| Q1 2021 | $1,042,000 | -25.3% | 45,790 | -28.7% | 0.33% | -16.3% |
| Q4 2020 | $1,395,000 | – | 64,250 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |